- Home
- INDP vs FMST Comparison
INDP vs FMST Comparison
Compare INDP & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- FMST
- Stock Information
- Founded
- INDP 2000
- FMST 2005
- Country
- INDP United States
- FMST Canada
- Employees
- INDP N/A
- FMST N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- INDP Health Care
- FMST Basic Materials
- Exchange
- INDP Nasdaq
- FMST Nasdaq
- Market Cap
- INDP 15.4M
- FMST 15.9M
- IPO Year
- INDP N/A
- FMST N/A
- Fundamental
- Price
- INDP $1.11
- FMST $2.57
- Analyst Decision
- INDP Strong Buy
- FMST
- Analyst Count
- INDP 1
- FMST 0
- Target Price
- INDP $12.00
- FMST N/A
- AVG Volume (30 Days)
- INDP 20.2K
- FMST 7.4K
- Earning Date
- INDP 11-04-2024
- FMST 01-01-0001
- Dividend Yield
- INDP N/A
- FMST N/A
- EPS Growth
- INDP N/A
- FMST N/A
- EPS
- INDP N/A
- FMST N/A
- Revenue
- INDP N/A
- FMST N/A
- Revenue This Year
- INDP N/A
- FMST N/A
- Revenue Next Year
- INDP N/A
- FMST N/A
- P/E Ratio
- INDP N/A
- FMST N/A
- Revenue Growth
- INDP N/A
- FMST N/A
- 52 Week Low
- INDP $1.03
- FMST $1.77
- 52 Week High
- INDP $3.25
- FMST $4.25
- Technical
- Relative Strength Index (RSI)
- INDP 34.05
- FMST 31.38
- Support Level
- INDP $1.10
- FMST $2.47
- Resistance Level
- INDP $1.22
- FMST $2.95
- Average True Range (ATR)
- INDP 0.12
- FMST 0.24
- MACD
- INDP 0.00
- FMST -0.05
- Stochastic Oscillator
- INDP 16.20
- FMST 12.20
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Lithium Resource & Technology Ltd is a hard-rock exploration company strategically located to capitalize on the growing EV appetite and is committed to being a supplier of North America's lithium feedstock. As the transition towards decarbonization, the company is focused on the exploration and growth of its five Lithium Lane Projects in Snow Lake Manitoba. It also has the Winston Gold/Silver Property in New Mexico, USA. The company mainly operates in one reportable operating segment being the acquisition and exploration of exploration and evaluation assets.